Understanding Why Pancreatic Cells Fail in Diabetes
Mechanisms of Beta Cell Failure
This research helps us understand why the special cells in the pancreas that make insulin stop working in people with diabetes, so we can find new ways to prevent and even reverse the condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11159461 on NIH RePORTER |
What this research studies
This research explores why the insulin-producing cells in the pancreas, called beta cells, stop working properly in people with diabetes. Scientists are looking for specific genetic, biochemical, and cellular pathways that go wrong, which could lead to new treatments. The work has already shown that beta cell failure happens in stages, including cells changing into other types or losing their original function. Recent discoveries include identifying specific cell types and activities in human diabetes that drive these changes, and finding genes involved in beta cell failure and recovery. The ultimate goal is to pinpoint new targets for medicines that could protect beta cells or help them recover, potentially preventing or reversing diabetes.
Who could benefit from this research
Good fit: Patients with adult-onset diabetes, or those at risk, could potentially benefit from future therapies developed from this fundamental understanding of beta cell failure.
Not a fit: Patients whose diabetes is not related to beta cell failure, or those with other forms of diabetes, may not directly benefit from this specific line of research.
Why it matters
Potential benefit: If successful, this work could lead to new treatments that prevent or even reverse the progression of adult-onset diabetes by protecting or restoring the function of insulin-producing cells.
How similar studies have performed: This grant has already led to several widely recognized discoveries about beta cell failure, building on a foundation of successful prior work.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Accili, Domenico — Columbia University Health Sciences
- Study coordinator: Accili, Domenico
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.